State Street Corp Maia Biotechnology, Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, State Street Corp holds 53,250 shares of MAIA stock, worth $98,512. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,250
Previous 53,250
-0.0%
Holding current value
$98,512
Previous $104,000
22.12%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MAIA
# of Institutions
22Shares Held
1.47MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA650KShares$1.2 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN237KShares$439,1080.19% of portfolio
-
Geode Capital Management, LLC Boston, MA214KShares$396,7080.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$145,2630.0% of portfolio
-
Centric Wealth Management68.2KShares$126,2580.03% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $20.2M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...